FindTrial
Sign In

To study the role of fatty acid binding protein in cases of blunt trauma abdomen.

The role of Intestinal Fatty Acid Binding Protein as a biomarker in the diagnosis of bowel and mesenteric injury in patients with blunt trauma abdomen - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055441
Enrollment
75
Registered
2023-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S399- Unspecified injury of abdomen, lower back, pelvis and external genitals

Interventions

Control Intervention1: nil: none

Sponsors

government medical collega and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) patients presenting with A/H/O blunt trauma abdomen with eFAST positive (2) age >18 years

Exclusion criteria

Exclusion criteria: (1) AGE (2) Obese patients (3) Patients presenting with penetrating trauma abdomen (4) patients who refuse to give consent

Design outcomes

Primary

MeasureTime frame
INTESTINAL FATTY ACID BINDING PROTEIN will be assed on presentation in emergencyTimepoint: INTESTINAL FATTY ACID BINDING PROTEIN levels on presentation—

Secondary

MeasureTime frame
to compare IFABP levels in blunt trauma abdomen cases amongst hollow viscus injury and solid organ injuryTimepoint: time of admission—

Countries

India

Contacts

Public ContactSHEENAM SAINI

GOVERNMENT MEDICAL COLLEGE AND HOSPITAL SECTOR 32 CHANDIGARH

rjVsharma63@gmail.com9646121562

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026